Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline

被引：12
|
作者：
Kooli, Ikbel [1 ]
Ben Brahim, Hajer [1 ]
Kilani, Mohamed [2 ]
Gannouni, Chokri [2 ]
Aouam, Abir [1 ]
Toumi, Adnene [1 ]
Loussaief, Chawki [1 ]
Hattab, Mohamed Nejib [2 ]
Chakroun, Mohamed [1 ]
机构：
[1] Fattouma Bourguiba Hosp, Dept Infect Dis, Farhat Hached St 5000, Monastir, Tunisia
[2] Fattouma Bourguiba Hosp, Dept Neurosurg, Monastir, Tunisia
来源：
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE | 2016年 / 5卷
关键词：
Nosocomial meningitis; Acinetobacter baumannii; Tigecycline; NEUROSURGICAL PATIENTS;
D O I：
10.1016/j.jgar.2015.12.003
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Tigecycline is a broad-spectrum antibiotic with activity against multidrug-resistant (MDR) bacteria. It has limited indications. Studies are necessary to elaborate new guidelines. Here we report a case of postoperative MDR Acinetobacter baumannii meningitis treated by tigecycline combined with colimycin for 21 days. The treatment was well tolerated with a favourable outcome. In conclusion, tigecycline was shown to be effective in a case of MDR A. baumannii meningitis. (C) 2016 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：62 / 63
页数：2
相关论文
共 50 条
  • [21] Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii
    Idelevich, Evgeny A.
    Freeborn, Dinah A.
    Seifert, Harald
    Becker, Karsten
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (04) : 360 - 362
  • [22] High tigecycline resistance in multidrug-resistant Acinetobacter baumannii -: authors' response
    Navon-Venezia, Shiri
    Leavitt, Azita
    Carmeli, Yehuda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (01) : 178 - 179
  • [23] Susceptibility to tigecycline among multidrug-resistant Acinetobacter baumannii clinical isolates
    Capone, A.
    D'Arezzo, S.
    Visca, P.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S588 - S589
  • [24] Epidemiology and Treatment of Multidrug-Resistant Acinetobacter baumannii
    Rocío Álvarez-Marín
    José Molina Gil-Bermejo
    José M. Cisneros
    Current Treatment Options in Infectious Diseases, 2014, 6 (4) : 409 - 424
  • [25] Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam
    Kendirli, T
    Aydin, HI
    Hacihamdioglu, D
    Gülgün, M
    Ünay, B
    Akin, R
    Lenk, MK
    Gökçay, E
    JOURNAL OF HOSPITAL INFECTION, 2004, 56 (04) : 328 - 328
  • [26] Multidrug-resistant Acinetobacter baumannii
    Abbo, A
    Navon-Venezia, S
    Orly, HM
    Krichali, T
    Siegman-Igra, Y
    Carmeli, Y
    EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 22 - 29
  • [27] Multidrug-resistant Acinetobacter baumannii
    Krcmery, Vladimir
    Kalavsky, Erich
    EMERGING INFECTIOUS DISEASES, 2007, 13 (06) : 943 - 944
  • [28] Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin
    De Pascale, G.
    Pompucci, A.
    Maviglia, R.
    Spanu, T.
    Bello, G.
    Mangiola, A.
    Scoppettuolo, G.
    MINERVA ANESTESIOLOGICA, 2010, 76 (11) : 957 - 960
  • [29] The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii
    Ye, Jung-Jr
    Lin, Huang-Shen
    Kuo, An-Jing
    Leu, Hsieh-Shong
    Chiang, Ping-Cherng
    Huang, Ching-Tai
    Lee, Ming-Hsun
    JOURNAL OF INFECTION, 2011, 63 (05) : 351 - 361
  • [30] A pharmacodynamic simulation to evaluate tigecycline in treatment of nosocomial pneumonia caused by multidrug-resistant Acinetobacter baumannii
    Ni, Wen-tao
    Liang, Bei-bei
    Cai, Yun
    Liu, Yin-ping
    Bai, Nan
    Cui, Jun-chang
    Wang, Rui
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 27 (03) : 463 - 467
12345